First Person in World to Get CCP Virus Vaccine Trial Describes Shot, 45-page Waiver

Jack Phillips
By Jack Phillips
April 14, 2020COVID-19
share
First Person in World to Get CCP Virus Vaccine Trial Describes Shot, 45-page Waiver
A pharmacist gives Jennifer Haller (L) the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus at the Kaiser Permanente Washington Health Research Institute in Seattle on March 16, 2020. (Ted S. Warren/AP Photo)

The first person in the world to receive the CCP virus vaccine described getting the shot.

Jennifer Haller, a 44-year-old mother of two from Seattle, told The Telegraph that the vaccine was comparable to the “regular flu shot” but said the test had “a ton of risks.” Haller said she responded to a request posted on Facebook for volunteers to partake in the trial for the vaccine.

“Even at that time we were all feeling so helpless,” she added. “There was nothing I could do to stop this global pandemic. Then I saw this opportunity come up and thought: ‘Well, maybe there is something I can do to contribute.’”

Haller’s family had expressed concerns about her getting the vaccine after she underwent a number of medical tests just to get it.

She was injected on March 16, as it was reported by The Associated Press. A doctor injected her with the experimental vaccine, named mRNA-1273, making her arm sore, NPR reported.

“Besides that, [there were] no side effects,” she said. “I wanted to do something because there’s so many millions of Americans that don’t have the same privileges that I’ve been given,” added Haller, who now works from home. “They’re losing their jobs. They are concerned about paying bills, feeding their family.”

Haller, according to the report, said she had to sign a 45-page waiver to enroll in the vaccine trial.

The injection was developed by the U.S. National Institutes of Health and the Massachusetts-based biotechnology company Moderna Inc.

During the trial, which is run by Seattle’s Kaiser Permanente Washington Health Research Institute, participants get two doses of the vaccine 28 days apart before officials monitor the patients for a year, according to reports.

“There were a ton of risks involved. But I’m a real positive person and the benefits of this far outweighed any risks in my mind,” Haller was quoted by the Telegraph as saying. Forty-four other adults joined her in the trial.

After receiving the shot, Haller said she had to keep a log for two weeks.

“The first day I had a slightly elevated temperature,” she said. “The second day my arm was pretty sore. But that was it—everything was all right after that.”

The Epoch Times refers to the novel coronavirus, which causes the disease COVID-19, as the CCP virus because the Chinese Communist Party’s coverup and mismanagement allowed the virus to spread throughout China before it was transmitted worldwide.

From The Epoch Times

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.
Comments